Bellicum Pharmaceuticals Competitors and Similar CompaniesClear all
Bluebird Bio's competitors and similar companies include Allogene Therapeutics.
 Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | ||
Founding Date | Founding Date 1992 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Somerville, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 32338% decrease | Employees 2263% decrease |
Valuation ($) | Valuation ($) 95.4 m | Valuation ($) 585.5 m |
Financial | ||
Net income | Net income ($240.7m) (FY, 2024) | Net income ($190.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 409m | Total funding raised $ 532m |
For sources of this data, please see the company profile
View Company Profiles
Allogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company